HDR Gateway logo
HDR Gateway logo

Bookmarks

COVID-19 Symptom Tracker - Oxford University

Safe People

Organisation name

Oxford University

Organisation sector

Academic Institute

Safe Projects

Project ID

1133

Lay summary

COVID-19 is an emerging disease and there is still a lot to learn. It is essential we harness the wealth of data available to help inform government decision making to optimise our response. This data is one such repository which could allow analyses which are otherwise not possible. The initial goals of the project fall into two broad areas: 1. Mapping the spread of infection There is an urgent need to map the spread and impact of COVID-19 across the UK. Researchers will analyse data from the C-19 Symptom Tracker app, which is now used by close to 2m people, to understand the spread of the illness and present these data to key decision makers and public health officials to help them identify areas that need focused attention through, for example, more targeted social distancing campaigns or diagnostic testing. 2. Understanding clinical predictors and symptomatology The New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) advises the government on the threat posed by new and emerging respiratory viruses. They have provided critical advice throughout the epidemic. This data set would be used by them across a range of their advisory actvities, including to inform the review of symptoms included in the national COVID-19 clinical case definition

Public benefit statement

To optimise advice to government decision making for COVID-19 through an evidence-based approach by utilising the best possible available data sources. Objectives: 1. To map COVID-19 across the UK and its 4 nations to inform UK, national and local decision making, with direction and priorities provided by government and those in charge of evaluating and dealing with the UK COVID-19 responses and planning. 2. To understand clinical predictors of infection and symptom presentation. 3. To refine the clinical case definition of COVID-19 in the UK. NB This work will be supported by NERVTAG who provide expert advise directly to government. This data set would be used by them across a range of their advisory IF YOU HAVE TICKED 'NOT REQUIRED' PLEASE SPECIFY THE REASONS: This project is being undertaken in the national interest during a national emergency, with information being provided across governments and health authorities. Research Ethics Not required THE PROJECT USES WILL USE ONLY ANONYMISED DATA, AND THEREFORE RESEARCH ETHICS REVIEW IS NOT REQUIRED Yes 3 of 6 actviities including to inform the reviews of COVID-19 case definition symptoms. Anticipated outcomes include: 1. Mapping disease spread across the UK 2. Mapping the impact of infection across the UK 3. Calculate crude and ageand sex-adjusted rates of COVID-19 infection by symptom description 4. Calculate the rates of confirmed test positivity at UK, national and lower layer super output area (LSOA) levels 5. Refine the clinical case definition of COVID-19 symptoms

Latest approval date

01/06/2020

Safe Data

Dataset(s) name
Data sensitivity level

Anonymous

Legal basis for provision of data under Article 6

(e) processing is necessary for the performance of a task carried out in the public interest or in the exercise of official authority vested in the controller;

Lawful conditions for provision of data under Article 9

(j) processing is necessary for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes in accordance with Article 89(1) based on Union or Member State law which shall be proportionate to the aim pursued, respect the essence of the right to data protection and provide for suitable and specific measures to safeguard the fundamental rights and the interests of the data subject.

Common Law Duty of Confidentiality

Not applicable

National data opt-out applied?

Not applicable

Safe Setting

Access type

TRE